On July 2023, SOPHiA GENETICS, a leading data-driven medicine company, has announced that the Centre Hospitalier de Bast...
Genenta Science: Temferon™ for the treatment of glioblastoma
Genenta Science, a clinical-stage immuno-oncology company, has received Orphan Drug Designation (ODD) from the European ...
The University of Milan approves the concession to Lendlease. Within the year the beginning of the works
The University of Milan has reached a significant milestone in the project of the new Scientific Campus in MIND. The Boa...
Polo GGB: excellence in genomic and bioinformatic analysis
The Innovation Pole of Genetic Genomics and Biology (Polo GGB) is a specialized center in the field of Life Sciences tha...
Angelini ventures invests in an American startup for new anti-epilepsy technology
Angelini Ventures, international venture capital company of Angelini Industries, has invested 6 million dollars in Caden...